GovChime
AWARDPURCHASE ORDERSmall business

Purchase order NNX17CL66PHUMANETICS CORPORATION

Overview

Award facts

Net obligations
$124.69K
$124,693of $124.69K potential value
Period of performance
Jun 9, 2017 to Dec 8, 2017
Ended
Modifications
0
Latest action Jun 6, 2017
Contract type
Purchase order
PIID NNX17CL66P

Description of requirement

IGF::OT::IGF THE CUMULATIVE DOSE OF RADIATION EXPOSURE TO OUR ASTRONAUTS REMAINS ONE OF THE LIMITING ROADBLOCKS TO LONGER DURATION MISSIONS IN SPACE. HUMANETICS CORPORATION (HUMANETICS) IS DEVELOPING A NOVEL RADIOPROTECTANT, BIO 300, FOR USE IN BOTH CLINICAL RADIOTHERAPY AND AS A RADIATION COUNTERMEASURE. BIO 300 IS A SAFE, SHELF-STABLE PHARMACEUTICAL WHICH HAS BEEN SHOWN TO MITIGATE BOTH THE ACUTE AND DELAYED EFFECTS OF RADIATION EXPOSURE. BIO 300 IS IN ADVANCED STAGES OF CLINICAL DEVELOPMENT, AND IS CURRENTLY BEING EVALUATED AS A RADIOPROTECTANT OF HEALTHY LUNG TISSUE DURING RADIOTHERAPY TREATMENT FOR NON-SMALL CELL LUNG CANCER IN A PHASE I/II TRIAL. ONE COMPONENT OF DEVELOPING RADIOPROTECTANTS FOR SPACE IS UNDERSTANDING IF THE THERAPY CAN PROTECT AGAINST BROAD-SPECTRUMS OF IONIZING RADIATION, RATHER THAN JUST MAN-MADE X-RAYS. THUS, THE OBJECTIVE OF THIS PROPOSAL IS TO EXAMINE BIO 300'S RADIOPROTECTIVE CAPABILITIES AGAINST MISSION-RELEVANT DOSES OF NEUTRON/GAMMA MIXED-FIELDS OF RADIATION. ANOTHER COMPONENT OF THE WORK PROPOSED HERE, IS TO UTILIZE A NOVEL CELLULAR PLATFORM OF TERMINALLY DIFFERENTIATED HUMAN CARDIOMYOCYTES TO INVESTIGATE DEGENERATIVE CONSEQUENCES OF RADIATION EXPOSURE IN A FUNCTIONAL HUMAN TISSUE MODEL. TOGETHER, THESE STUDIES WILL VALIDATE THE UTILITY OF BIO 300 AS A COUNTERMEASURE FOR EXTRATERRESTRIAL RADIATION EXPOSURES.

Dates and value

Award date
Signed on Jun 6, 2017
Potential end of performance
Dec 7, 2017
Current value
$124,693Base and exercised options
Potential value (if all options are exercised)
$124,693

Obligations by fiscal year of action

  • FY2017: $124,693

Total across 1 fiscal year: $124,693

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 6, 2017. View on USAspending · Recipient on SAM.gov

Recipient

LocationEDINA, MN
UEIMSRQYLLQLYQ5
Business sizeSmall businessSize at award, per the contracting officer

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. National Aeronautics and Space Administration
  2. NASA SHARED SERVICES CENTER
Funded by
  1. National Aeronautics and Space Administration
  2. NASA SHARED SERVICES CENTER
Funded from
Space technology (DIRECT)Program activities080-0131Federal accounts (agency financial reports)

Place of performance

Place of performance
Minneapolis, Hennepin County, Minnesota 55435-6012
Congressional district (place of performance)
MN-03As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competition after exclusion of sourcesD
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Small business set aside - totalSBA
Contract pricing
Firm fixed priceJ
Offers received
500

Contract details

Subcontracting plan
Plan not requiredB
Major program
Protecting cardiomyocytes from mixed fields of radiation by bio 300
Service Contract Act labor standards
No
Commercial procedures
Commercial item procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jun 6, 2017Base obligation at award: $124,693
Latest action
Jun 6, 2017 — Base awardModification 0; obligation change +$124,693
Actions by type
  • Base award1
1 actions recorded, Jun 6, 2017 to Jun 6, 2017; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$124,693
Latest action: change in base and all options
$124,693

Socio-economic and policy

Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Research program (SBIR/STTR)
Small business innovation research program phase i actionSR1
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Purchase orderB
Awarding agency code
8000
Awarding sub-tier code
8000
Contracting office code
80NSSC
Transactions recorded under this award key
1

Funding

Funding agency code
8000
Funding sub-tier code
8000
Funding office code
80NSSC
Treasury accounts
  • 080-2017/2018-0131-000
Object classes
  • 25.5: Research and development contracts